Objective: To assess the safety profile of acarbose treatment over a 1-year period at a dose range of 50 300mg three times daily in patients with type 1 or type 2 diabetes mellitus. Results ...

Clin Drug Invest. 2005;25(9):579-587. Acarbose was well tolerated by the majority of patients in spite of the very high dosing regimen used. Median treatment duration was similar for acarbose and ...